Abstract:Introduction: Hypoxic persistent pulmonary hypertension in the newborn (PPHN) is usually treated with oxygen and inhaled nitric oxide (NO), both pulmonary arterial relaxants. But treatment failure with NO occurs in 25% of cases. We previously demonstrated that 72 h exposure to hypoxia, modeling PPHN, sensitized pulmonary artery smooth muscle cells (PASMC) to the contractile agonist thromboxane and inhibited relaxant adenylyl cyclase (AC) activity. Methods: In this study, we examined the effects of sodium nitroprusside (SNP), as NO donor, on the thromboxane-mediated contraction and NO-independent relaxation pathways and on reactive oxygen species (ROS) accumulation in PASMC. In addition, we examined the effect of the peroxynitrite scavenger 5,10,15,20-Tetrakis (4-sulfonatophenyl)porphyrinato Iron (III) (FeTPPS) on these processes. Results: Exposure of PASMC to 72 h hypoxia increased total intracellular ROS compared to normoxic control cells and this was mitigated by treatment of cells with either SNP or FeTPPS. Total protein nitrosylation was increased in hypoxic PASMC compared to controls. Both normoxic and hypoxic cells treated with SNP exhibited increased total protein nitrosylation and intracellular nitrite; this was reduced by treatment with FeTPPS. While cell viability and mitochondrial number were unchanged by hypoxia, mitochondrial activity was decreased compared to controls; addition of FeTPPS did not alter this. Basal and maximal mitochondrial metabolism and ATP turnover were reduced in hypoxic PASMC compared to controls. Hypoxic PASMC had higher basal Ca2+, and a heightened peak Ca2+ response to thromboxane challenge compared to controls. Addition of SNP further elevated the peak Ca2+ response, while addition of FeTPPS brought peak Ca2+ response down to control levels. AC mediated relaxation was impaired in hypoxic PASMC compared to controls but was normalized following treatment with FeTPPS. Addition of SNP inhibited adenylyl cyclase activity in both normoxic and hypoxic PASMC. Moreover, addition of the Ca2+ chelator BAPTA improved AC activity, but the effect was minimal. Discussion: We conclude that NO independently augments contraction and inhibits relaxation pathways in hypoxic PASMC, in part by a mechanism involving nitrogen radical formation and protein nitrosylation. These observations may partially explain impaired effectiveness of NO when treating hypoxic pulmonary hypertension.

Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide.

Effects of Hypoxia on Levels of Nitric Oxide, Endothelin- 1 and Inducible Nitric Oxide Synthase Mrna Expression in Cultured Human Umbilical Vein Endothelial Cells

Hemopressin, a hemoglobin fragment, dilates the rat systemic vascular bed through release of nitric oxide.

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

The Regulating Effect of Heme Oxygenase/carbon Monoxide on Hypoxic Pulmonary Vascular Structural Remodeling

Effects of hypercapnia with and without acidosis on hypoxic pulmonary vasoconstriction

A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension.

Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction—Molecular Mechanisms and Clinical Significance

Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension

Regulative Effects of Hawthorn Leave Flavonoids on Cytotoxicity, NO and Ca2+ in Hypoxia-Treated Human Umbilical Vein Endothelial Cells.

Impaired Release of ATP from Red Blood Cells of Humans with Primary Pulmonary Hypertension

Effects of Different Degree Acute Normovolemic Hemodilution on Lung and Systemic Oxygen Metabolism in Rabbits

The dual roles of red blood cells in tissue oxygen delivery: oxygen carriers and regulators of local blood flow

Erythroid anion transport, nitric oxide, and blood pressure

Impact of nitric oxide on platelet-derived growth factor expression in intrapulmonary arteries of rats with hypoxic pulmonary vascular structural remodeling

Effects of different nitric oxide synthases on pulmonary and systemic hemodynamics in hypoxic stress rat model

Nitric Oxide in the Evaluation of Congenital Heart Disease with Pulmonary Hypertension: Factors Related to Nitric Oxide Response

Alleviation of Hypoxic Pulmonary Vascular Structural Remodeling by L-arginine.

Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone

Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-γ axis

[Effect of Adrenomedullin 1-50 on Chronic Hypoxic Pulmonary Hypertension in Rats].